5d 1m 3m 1y 5y 10y
There are 2 articles on this stock available only to PRO subscribers.
There are no Transcripts on KBIO.
PR Newswire (Feb 11, 2014)
PR Newswire (Feb 5, 2014)
PR Newswire (Jan 29, 2014)
PR Newswire (Jan 7, 2014)
KBIO vs. ETF Alternatives
KaloBios Pharmaceuticals Inc is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics for diseases that represent a significant burden to society and to patients and their families.